Authenticity Check

CID : 2402410522
Name : MS.NOOR SABA
Use a QR Code Scanner
Age / Gender : 22 Years / Female Application To Scan the Code

Consulting Dr. : JYOTSNA SINGH Collected : 24-Jan-2024 / 15:56

Reg. Location : JILLA IVF CENTER-ANDHERI WEST Reported : 24-Jan-2024 / 17:27

CBC (Complete Blood Count), Blood

PARAMETER RESULTS BIOLOGICAL REF RANGE METHOD
RBC PARAMETERS
Haemoglobin 11.0 12.0-15.0 g/dL Spectrophotometric
RBC 3.95 3.8-4.8 mil/cmm Elect. Impedance
PCV 34.8 36-46 % Calculated
MCV 88.0 80-100 fl Measured
MCH 27.8 27-32 pg Calculated
MCHC 31.5 31.5-34.5 g/dL Calculated
RDW 15.7 11.6-14.0 % Calculated
WBC PARAMETERS
WBC Total Count 8120 4000-10000 /cmm Elect. Impedance
WBC DIFFERENTIAL AND ABSOLUTE COUNTS
Lymphocytes 33.3 20-40 %
Absolute Lymphocytes 2704.0 1000-3000 /cmm Calculated
Monocytes 6.0 2-10 %
Absolute Monocytes 487.2 200-1000 /cmm Calculated
Neutrophils 53.4 40-80 %
Absolute Neutrophils 4336.1 2000-7000 /cmm Calculated
Eosinophils 7.3 1-6 %
Absolute Eosinophils 592.8 20-500 /cmm Calculated
Basophils 0.0 0.1-2 %
Absolute Basophils 0.0 20-100 /cmm Calculated
Immature Leukocytes -

WBC Differential Count by Absorbance & Impedance method/Microscopy.

PLATELET PARAMETERS
Platelet Count 189000 150000-400000 /cmm Elect. Impedance
MPV 13.4 6-11 fl Measured
PDW 33.1 11-18 % Calculated
RBC MORPHOLOGY
Hypochromia -
Microcytosis -
Macrocytosis -

Page 1 of 4
 Authenticity Check

CID : 2402410522
Name : MS.NOOR SABA
Use a QR Code Scanner
Age / Gender : 22 Years / Female Application To Scan the Code

Consulting Dr. : JYOTSNA SINGH Collected : 24-Jan-2024 / 15:56

Reg. Location : JILLA IVF CENTER-ANDHERI WEST Reported : 24-Jan-2024 / 17:27

Macrocytosis -
Anisocytosis -
Poikilocytosis -
Polychromasia -
Target Cells -
Basophilic Stippling -
Normoblasts -
Others Normocytic,Normochromic
WBC MORPHOLOGY -
PLATELET MORPHOLOGY -
COMMENT Eosinophilia

Specimen: EDTA Whole Blood

*Sample processed at SUBURBAN DIAGNOSTICS (INDIA) PVT. LTD CPL, Andheri West
*** End Of Report ***

Dr.JYOT THAKKER
M.D. (PATH), DPB
Pathologist and AVP( Medical
Services)

Page 2 of 4
 Authenticity Check

CID : 2402410522
Name : MS.NOOR SABA
Use a QR Code Scanner
Age / Gender : 22 Years / Female Application To Scan the Code

Consulting Dr. : JYOTSNA SINGH Collected : 24-Jan-2024 / 15:56

Reg. Location : JILLA IVF CENTER-ANDHERI WEST Reported : 24-Jan-2024 / 19:52

CREATININE
PARAMETER RESULTS BIOLOGICAL REF RANGE METHOD
CREATININE, Serum 0.65 0.51-0.95 mg/dl Enzymatic
eGFR, Serum 128 (ml/min/1.73sqm) Calculated
Normal or High: Above 90
Mild decrease: 60-89
Mild to moderate decrease: 45-
59
Moderate to severe decrease:30
-44
Severe decrease: 15-29
Kidney failure:<15
Note: eGFR estimation is calculated using 2021 CKD-EPI GFR equation w.e.f 16-08-2023

*Sample processed at SUBURBAN DIAGNOSTICS (INDIA) PVT. LTD CPL, Andheri West
*** End Of Report ***

Dr.JYOT THAKKER
M.D. (PATH), DPB
Pathologist and AVP( Medical
Services)

Page 3 of 4
 Authenticity Check

CID : 2402410522
Name : MS.NOOR SABA
Use a QR Code Scanner
Age / Gender : 22 Years / Female Application To Scan the Code

Consulting Dr. : JYOTSNA SINGH Collected : 24-Jan-2024 / 15:56

Reg. Location : JILLA IVF CENTER-ANDHERI WEST Reported : 24-Jan-2024 / 20:39

GLYCOSYLATED HEMOGLOBIN (HbA1c)

PARAMETER RESULTS BIOLOGICAL REF RANGE METHOD
Glycosylated Hemoglobin 5.2 Non-Diabetic Level: < 5.7 % HPLC
(HbA1c), EDTA WB - CC Prediabetic Level: 5.7-6.4 %
Diabetic Level: >/= 6.5 %
Estimated Average Glucose 102.5 mg/dl Calculated
(eAG), EDTA WB - CC

Intended use:
‡ In patients who are meeting treatment goals, HbA1c test should be performed at least 2 times a year
‡ In patients whose therapy has changed or who are not meeting glycemic goals, it should be performed quarterly
‡ For microvascular disease prevention, the HbA1C goal for non pregnant adults in general is Less than 7%.
Clinical Significance:
‡ HbA1c, Glycosylated hemoglobin or glycated hemoglobin, is hemoglobin with glucose molecule attached to it.
‡ The HbA1c test evaluates the average amount of glucose in the blood over the last 2 to 3 months by measuring the percentage of
glycosylated hemoglobin in the blood.

Test Interpretation:
‡ The HbA1c test evaluates the average amount of glucose in the blood over the last 2 to 3 months by measuring the percentage of
Glycosylated hemoglobin in the blood.
‡ HbA1c test may be used to screen for and diagnose diabetes or risk of developing diabetes.
‡ To monitor compliance and long term blood glucose level control in patients with diabetes.
‡ Index of diabetic control, predicting development and progression of diabetic micro vascular complications.
Factors affecting HbA1c results:
Increased in: High fetal hemoglobin, Chronic renal failure, Iron deficiency anemia, Splenectomy, Increased serum triglycerides, Alcohol
ingestion, Lead/opiate poisoning and Salicylate treatment.

Decreased in: Shortened RBC lifespan (Hemolytic anemia, blood loss), following transfusions, pregnancy, ingestion of large amount of Vitamin
E or Vitamin C and Hemoglobinopathies

Reflex tests: Blood glucose levels, CGM (Continuous Glucose monitoring)

References: ADA recommendations, AACC, Wallach·s interpretation of diagnostic tests 10th edition.

*Sample processed at SUBURBAN DIAGNOSTICS (INDIA) PVT. LTD CPL, Andheri West
*** End Of Report ***

Dr.ANUPA DIXIT
M.D.(PATH)
Consultant Pathologist & Lab Director

Page 4 of 4